Page last updated: 2024-08-24

naphthalimides and Myelodysplastic Syndromes

naphthalimides has been researched along with Myelodysplastic Syndromes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feldman, EJ1

Other Studies

1 other study(ies) available for naphthalimides and Myelodysplastic Syndromes

ArticleYear
Does therapy-related AML have a poor prognosis, independent of the cytogenetic/molecular determinants?
    Best practice & research. Clinical haematology, 2011, Volume: 24, Issue:4

    Topics: Adenine; Anthracyclines; Antineoplastic Agents; Biomarkers, Tumor; Cytarabine; Cytogenetics; Female; Germany; Humans; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Naphthalimides; Naphthyridines; Organophosphonates; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Thiazoles

2011